Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinitis | 18 | 2023 | 747 | 3.430 |
Why?
|
| Sinusitis | 19 | 2023 | 991 | 3.150 |
Why?
|
| Endoscopy | 18 | 2023 | 1852 | 2.550 |
Why?
|
| Nasal Polyps | 7 | 2023 | 395 | 2.040 |
Why?
|
| Paranasal Sinuses | 7 | 2021 | 265 | 2.030 |
Why?
|
| Turbinates | 2 | 2019 | 65 | 1.160 |
Why?
|
| Decision Trees | 5 | 2020 | 505 | 0.980 |
Why?
|
| Skull Base | 3 | 2017 | 292 | 0.920 |
Why?
|
| Cost-Benefit Analysis | 8 | 2021 | 5494 | 0.760 |
Why?
|
| Natural Orifice Endoscopic Surgery | 2 | 2019 | 119 | 0.720 |
Why?
|
| Cautery | 1 | 2020 | 71 | 0.690 |
Why?
|
| Suction | 1 | 2020 | 266 | 0.650 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2020 | 121 | 0.640 |
Why?
|
| Skull Base Neoplasms | 2 | 2024 | 270 | 0.610 |
Why?
|
| Frontal Sinus | 1 | 2017 | 51 | 0.570 |
Why?
|
| Nasopharynx | 1 | 2020 | 400 | 0.570 |
Why?
|
| Drug-Eluting Stents | 2 | 2020 | 681 | 0.540 |
Why?
|
| Rhinoplasty | 1 | 2019 | 238 | 0.490 |
Why?
|
| Dacryocystorhinostomy | 3 | 2020 | 78 | 0.480 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2017 | 242 | 0.470 |
Why?
|
| Smell | 1 | 2017 | 259 | 0.470 |
Why?
|
| Olfaction Disorders | 1 | 2017 | 224 | 0.460 |
Why?
|
| Chronic Disease | 15 | 2023 | 9317 | 0.460 |
Why?
|
| Quality of Life | 9 | 2023 | 13362 | 0.440 |
Why?
|
| Outpatients | 1 | 2021 | 1596 | 0.430 |
Why?
|
| Mucocele | 1 | 2013 | 51 | 0.420 |
Why?
|
| Otolaryngology | 4 | 2022 | 693 | 0.420 |
Why?
|
| Quality-Adjusted Life Years | 6 | 2020 | 1723 | 0.400 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2022 | 1878 | 0.390 |
Why?
|
| Markov Chains | 4 | 2021 | 965 | 0.350 |
Why?
|
| Models, Economic | 4 | 2021 | 714 | 0.340 |
Why?
|
| MEDLINE | 1 | 2008 | 119 | 0.310 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 3512 | 0.300 |
Why?
|
| Medicare | 5 | 2022 | 6775 | 0.300 |
Why?
|
| Ambulatory Care | 2 | 2015 | 2769 | 0.280 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 1323 | 0.260 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2008 | 303 | 0.240 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 2 | 2020 | 324 | 0.230 |
Why?
|
| Nasolacrimal Duct | 2 | 2020 | 79 | 0.210 |
Why?
|
| Biological Products | 2 | 2022 | 913 | 0.200 |
Why?
|
| Lacrimal Duct Obstruction | 2 | 2019 | 53 | 0.200 |
Why?
|
| Cadaver | 3 | 2020 | 1358 | 0.190 |
Why?
|
| Tampons, Surgical | 1 | 2021 | 10 | 0.190 |
Why?
|
| Aerosols | 2 | 2020 | 635 | 0.180 |
Why?
|
| Nose | 2 | 2024 | 521 | 0.180 |
Why?
|
| Epistaxis | 1 | 2021 | 112 | 0.170 |
Why?
|
| Dilatation | 2 | 2020 | 307 | 0.170 |
Why?
|
| Dacryocystitis | 1 | 2020 | 68 | 0.170 |
Why?
|
| Nose Diseases | 1 | 2020 | 79 | 0.170 |
Why?
|
| Meningioma | 2 | 2024 | 1216 | 0.170 |
Why?
|
| Humans | 47 | 2024 | 761098 | 0.160 |
Why?
|
| Emergency Service, Hospital | 2 | 2015 | 7873 | 0.150 |
Why?
|
| Asthma | 1 | 2017 | 6229 | 0.150 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2019 | 72 | 0.150 |
Why?
|
| Health Services Accessibility | 2 | 2015 | 5427 | 0.150 |
Why?
|
| Reoperation | 2 | 2019 | 4304 | 0.150 |
Why?
|
| Rhinometry, Acoustic | 1 | 2017 | 8 | 0.140 |
Why?
|
| Device Approval | 1 | 2019 | 163 | 0.140 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 251 | 0.140 |
Why?
|
| Off-Label Use | 1 | 2019 | 185 | 0.140 |
Why?
|
| Eye Neoplasms | 1 | 2019 | 307 | 0.140 |
Why?
|
| Granuloma | 1 | 2019 | 327 | 0.140 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 273 | 0.130 |
Why?
|
| Internet | 1 | 2008 | 3094 | 0.130 |
Why?
|
| Cost Savings | 1 | 2021 | 912 | 0.130 |
Why?
|
| Treatment Outcome | 13 | 2024 | 64670 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2021 | 637 | 0.130 |
Why?
|
| Larynx, Artificial | 1 | 2015 | 69 | 0.120 |
Why?
|
| Meningeal Neoplasms | 1 | 2024 | 1246 | 0.120 |
Why?
|
| Pneumonia, Aspiration | 1 | 2015 | 145 | 0.120 |
Why?
|
| Nasal Mucosa | 1 | 2017 | 415 | 0.120 |
Why?
|
| Shock, Septic | 1 | 2021 | 769 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 1664 | 0.110 |
Why?
|
| Clostridium Infections | 1 | 2021 | 557 | 0.110 |
Why?
|
| Laryngectomy | 1 | 2015 | 243 | 0.110 |
Why?
|
| Craniotomy | 1 | 2017 | 741 | 0.110 |
Why?
|
| Conflict of Interest | 1 | 2018 | 554 | 0.110 |
Why?
|
| United States | 12 | 2023 | 72337 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 1603 | 0.100 |
Why?
|
| Prospective Studies | 8 | 2023 | 54419 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3094 | 0.100 |
Why?
|
| Hypopituitarism | 1 | 2014 | 250 | 0.100 |
Why?
|
| Hypersensitivity | 1 | 2021 | 1167 | 0.100 |
Why?
|
| Voice | 1 | 2015 | 268 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3216 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2019 | 1469 | 0.100 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 26068 | 0.100 |
Why?
|
| Fixatives | 1 | 2010 | 90 | 0.090 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2010 | 123 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 2000 | 0.090 |
Why?
|
| Prosthesis-Related Infections | 1 | 2015 | 488 | 0.090 |
Why?
|
| Acute Disease | 3 | 2015 | 7240 | 0.090 |
Why?
|
| Esophagus | 1 | 2015 | 1033 | 0.080 |
Why?
|
| Trachea | 1 | 2015 | 1090 | 0.080 |
Why?
|
| Paraffin Embedding | 1 | 2010 | 302 | 0.080 |
Why?
|
| Male | 17 | 2023 | 360675 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2014 | 970 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1812 | 0.080 |
Why?
|
| Formaldehyde | 1 | 2010 | 357 | 0.080 |
Why?
|
| Postoperative Complications | 5 | 2019 | 15634 | 0.080 |
Why?
|
| Surgical Flaps | 1 | 2017 | 1670 | 0.080 |
Why?
|
| Female | 18 | 2023 | 392458 | 0.080 |
Why?
|
| Middle Aged | 11 | 2023 | 220835 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2015 | 2115 | 0.080 |
Why?
|
| Particulate Matter | 1 | 2020 | 2597 | 0.080 |
Why?
|
| Absorbable Implants | 2 | 2022 | 338 | 0.080 |
Why?
|
| Adult | 11 | 2023 | 221083 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 3689 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2508 | 0.060 |
Why?
|
| Aged | 10 | 2023 | 169266 | 0.060 |
Why?
|
| Leiomyosarcoma | 1 | 2009 | 422 | 0.060 |
Why?
|
| Health Status | 1 | 2018 | 4077 | 0.060 |
Why?
|
| Headache | 1 | 2013 | 1255 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2024 | 80673 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4583 | 0.060 |
Why?
|
| Nasal Lavage | 1 | 2023 | 17 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2015 | 1937 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 1767 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2009 | 1149 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2015 | 2494 | 0.050 |
Why?
|
| Budesonide | 1 | 2023 | 158 | 0.050 |
Why?
|
| Nasal Cavity | 1 | 2024 | 304 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18385 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12975 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 1420 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 41486 | 0.040 |
Why?
|
| Sneezing | 1 | 2020 | 17 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 39121 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2008 | 1126 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15845 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2022 | 849 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 510 | 0.040 |
Why?
|
| Tissue Adhesions | 1 | 2019 | 218 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2008 | 5870 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 12058 | 0.040 |
Why?
|
| Steroids | 1 | 2022 | 929 | 0.040 |
Why?
|
| Nasal Obstruction | 1 | 2019 | 160 | 0.030 |
Why?
|
| Health Expenditures | 2 | 2022 | 2363 | 0.030 |
Why?
|
| Resource Allocation | 1 | 2018 | 350 | 0.030 |
Why?
|
| Granulation Tissue | 1 | 2015 | 92 | 0.030 |
Why?
|
| Particle Size | 1 | 2020 | 1649 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2015 | 75 | 0.030 |
Why?
|
| Glioma | 1 | 2010 | 3452 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 1436 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2023 | 1661 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 3882 | 0.030 |
Why?
|
| Punctures | 1 | 2015 | 366 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 58946 | 0.030 |
Why?
|
| Voice Quality | 1 | 2015 | 225 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 4013 | 0.030 |
Why?
|
| Laryngeal Neoplasms | 1 | 2015 | 514 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 989 | 0.020 |
Why?
|
| Medicaid | 2 | 2015 | 2814 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 7804 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12670 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 591 | 0.020 |
Why?
|
| Young Adult | 2 | 2018 | 59199 | 0.020 |
Why?
|
| Office Visits | 1 | 2015 | 594 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2015 | 399 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 1204 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8663 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2010 | 153 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 473 | 0.020 |
Why?
|
| Oligodendroglioma | 1 | 2010 | 278 | 0.020 |
Why?
|
| Time Factors | 2 | 2023 | 39953 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 9025 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 1067 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2015 | 2424 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2510 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2009 | 638 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6781 | 0.020 |
Why?
|
| Integrases | 1 | 2009 | 518 | 0.020 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2009 | 407 | 0.020 |
Why?
|
| Wound Healing | 1 | 2017 | 2801 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 1703 | 0.020 |
Why?
|
| Income | 1 | 2015 | 1868 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2019 | 3238 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 2420 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 834 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2009 | 1217 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 9648 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2915 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3450 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 21357 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1837 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20120 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 3352 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 2914 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2015 | 4673 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18217 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5775 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9518 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 3499 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14676 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2009 | 4386 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14393 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16947 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2008 | 2577 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9416 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 5077 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74219 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 13506 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 168083 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 88271 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 29672 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 14023 | 0.000 |
Why?
|
| Child | 1 | 2015 | 80134 | 0.000 |
Why?
|
| Mice | 1 | 2009 | 81324 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_